Forward Pharma A/S (FWP)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.

Forward Pharma A/S (NASDAQ:FWP): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.

A high majority of hedge fund managers delivered a terrible performance in 2015 and widely-known value investor Seth Klarman was no exception.

Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman's $31 billion fund, Baupost Group, has achieved average annual returns of 17% a year for over 30 years, ...

Mark Lampert’s Biotechnology Value Fund recently filed its 13F with the U.S. Securities and Exchange Commission for the reporting period of March 31.

Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns.